Immunoreactivity to WT1 peptide vaccine is associated with prognosis in elderly patients with acute myeloid leukemia: follow-up study of randomized phase II trial of OCV-501, an HLA class II-binding WT1 polypeptide.

Cancer Immunol Immunother · 2023 · PMC10123586 · PMID 37093243

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Regarding the fourth finding, the IFNγ-response was observed not only in the OCV-501 group but also in a small number of the placebo group, and both the IFNγ-response subgroups showed a trend towards a better prognosis than the IFNγ-nonresponse subgroup (data not shown).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.